Literature DB >> 21514377

Roles of VRK1 as a new player in the control of biological processes required for cell division.

Alberto Valbuena1, Marta Sanz-García, Inmaculada López-Sánchez, Francisco M Vega, Pedro A Lazo.   

Abstract

Cell division, in addition to an accurate transmission of genetic information to daughter cells, also requires the temporal and spatial coordination of several biological processes without which cell division would not be feasible. These processes include the temporal coordination of DNA replication and chromosome segregation, regulation of nuclear envelope disassembly and assembly, chromatin condensation and Golgi fragmentation for its redistribution into daughter cells, among others. However, little is known regarding regulatory proteins and signalling pathways that might participate in the coordination of all these different biological functions. Such regulatory players should directly have a role in the processes leading to cell division. VRK1 (Vaccinia-related kinase 1) is an early response gene required for cyclin D1 expression, regulates p53 by a specific Thr18 phosphorylation, controls chromatin condensation by histone phosphorylation, nuclear envelope assembly by phosphorylation of BANF1, and participates in signalling required for Golgi fragmentation late in the G2 phase. We propose that VRK1, a Ser-Thr kinase, might be a candidate to play an important coordinator role in these cell division processes as part of a novel signalling pathway.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514377     DOI: 10.1016/j.cellsig.2011.04.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  42 in total

1.  VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling.

Authors:  Isabel F Fernández; Luis G Pérez-Rivas; Sandra Blanco; Adrián A Castillo-Dominguez; José Lozano; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

2.  Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly.

Authors:  Claudia Gonzaga-Jauregui; Timothy Lotze; Leila Jamal; Samantha Penney; Ian M Campbell; Davut Pehlivan; Jill V Hunter; Suzanne L Woodbury; Gerald Raymond; Adekunle M Adesina; Shalini N Jhangiani; Jeffrey G Reid; Donna M Muzny; Eric Boerwinkle; James R Lupski; Richard A Gibbs; Wojciech Wiszniewski
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

3.  EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.

Authors:  Nicolò Riggi; Birgit Knoechel; Shawn M Gillespie; Bradley E Bernstein; Miguel N Rivera; Esther Rheinbay; Gaylor Boulay; Mario L Suvà; Nikki E Rossetti; Wannaporn E Boonseng; Ozgur Oksuz; Edward B Cook; Aurélie Formey; Anoop Patel; Melissa Gymrek; Vishal Thapar; Vikram Deshpande; David T Ting; Francis J Hornicek; G Petur Nielsen; Ivan Stamenkovic; Martin J Aryee
Journal:  Cancer Cell       Date:  2014-10-30       Impact factor: 31.743

4.  Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Authors:  Marta Sanz-García; Diana M Monsalve; Ana Sevilla; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

5.  Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.

Authors:  Ender Karaca; Stefan Weitzer; Davut Pehlivan; Hiroshi Shiraishi; Tasos Gogakos; Toshikatsu Hanada; Shalini N Jhangiani; Wojciech Wiszniewski; Marjorie Withers; Ian M Campbell; Serkan Erdin; Sedat Isikay; Luis M Franco; Claudia Gonzaga-Jauregui; Tomasz Gambin; Violet Gelowani; Jill V Hunter; Gozde Yesil; Erkan Koparir; Sarenur Yilmaz; Miguel Brown; Daniel Briskin; Markus Hafner; Pavel Morozov; Thalia A Farazi; Christian Bernreuther; Markus Glatzel; Siegfried Trattnig; Joachim Friske; Claudia Kronnerwetter; Matthew N Bainbridge; Alper Gezdirici; Mehmet Seven; Donna M Muzny; Eric Boerwinkle; Mustafa Ozen; Tim Clausen; Thomas Tuschl; Adnan Yuksel; Andreas Hess; Richard A Gibbs; Javier Martinez; Josef M Penninger; James R Lupski
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

6.  Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.

Authors:  Yeen Shian Ngow; Sreekanth Rajan; Hong Ye; Ho Sup Yoon
Journal:  Protein Sci       Date:  2018-12-20       Impact factor: 6.725

7.  Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.

Authors:  Nouhou Ibrahim; April Wicklund; Augusta Jamin; Matthew S Wiebe
Journal:  Virology       Date:  2013-07-24       Impact factor: 3.616

8.  Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2.

Authors:  Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

9.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

10.  Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.

Authors:  Emma Glamuzina; Ruth Brown; Kieran Hogarth; Dawn Saunders; Isabelle Russell-Eggitt; Matthew Pitt; Carlos de Sousa; Shamima Rahman; Garry Brown; Stephanie Grunewald
Journal:  J Inherit Metab Dis       Date:  2011-11-16       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.